TrialBMC cancer2022

Four cycles of R-CHOP followed by two applications of rituximab based on negative interim PET/CT: an analysis of a prospective trial.

Jia Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.